Lipocine Inc.
LPCN
$3.03
$0.01410.47%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 563.26% | -97.31% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 563.26% | -97.31% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 563.26% | -97.31% | |||
| SG&A Expenses | -20.68% | 28.56% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 38.61% | 12.24% | |||
| Operating Income | -15.03% | -235.24% | |||
| Income Before Tax | -18.29% | -204.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -18.27% | -204.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -18.27% | -204.64% | |||
| EBIT | -15.03% | -235.24% | |||
| EBITDA | -15.12% | -232.89% | |||
| EPS Basic | -18.18% | -204.65% | |||
| Normalized Basic EPS | -18.22% | -204.61% | |||
| EPS Diluted | -17.74% | -211.82% | |||
| Normalized Diluted EPS | -18.22% | -211.17% | |||
| Average Basic Shares Outstanding | 0.06% | 0.01% | |||
| Average Diluted Shares Outstanding | 0.06% | -5.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||